H-ras and K-ras mutations in soft tissue sarcoma: Comparative studies of sarcomas from Korean and American patients

作者: Jinyoung Yoo , Robert A. Robinson

DOI: 10.1002/(SICI)1097-0142(19990701)86:1<58::AID-CNCR10>3.0.CO;2-S

关键词: CarcinogenesisMutationMedicineInternal medicineSoft tissue sarcomaTumor progressionOncologySarcomaRhabdomyosarcomaPoint mutationCancerPathology

摘要: BACKGROUND The authors' recent investigation of Korean patients with sarcoma has suggested that ras gene activation may play a role in oncogenesis. The authors attempted to extend the mutation analysis sarcomas American determine whether there were racial or geographic factors relevant initiation progression sarcoma. METHODS H-ras and K-ras genes examined obtained from midwestern U. S. using polymerase chain reaction technique direct automated sequencing analysis. Tumors studied included 29 malignant fibrous histiocytomas, 7 liposarcomas, 5 rhabdomyosarcomas, 9 leiomyosarcomas. RESULTS Of 50 evaluated, only 1 (2%) definable was found; GGC AGC transition at codon 12 H-ras found rhabdomyosarcoma. None had mutation. rates incidence point mutations these samples much lower (H-ras: 2%; 95% confidence interval [95% CI], 0-11.5% K-ras: 0%) than described for both studies 16%; CI, 5.2-26.8% 44%; 29.5-58.5%). CONCLUSIONS Although reason this discrepancy is not clear, no major differences histology clinical stages. Based on study previous 45 tumor samples, conclude differing genetic and/or environmental mechanisms can affect development progression. Mutation appears be uncommon occurring patients, suggesting by does significant pathogenesis patients. Cancer 1999;86:58–63. © 1999 Society.

参考文章(22)
Stratton Mr, Fletcher Cd, Warren W, Moss S, Clark J, Fisher C, Patterson H, Gusterson Ba, Ball A, Thomas M, Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene. Oncogene. ,vol. 5, pp. 1297- 1301 ,(1990)
Robinson Ra, Lee Jy, Yoo J, H-ras and K-ras gene mutations in primary human soft tissue sarcoma: concomitant mutations of the ras genes. Modern Pathology. ,vol. 12, pp. 775- 780 ,(1999)
R. M. Bohle, R. Repp, H. M. Altmannsberger, H. Kosmehl, A. Borkhardt, S. Brettreich, Single somatic ras gene point mutation in soft tissue malignant fibrous histiocytomas. American Journal of Pathology. ,vol. 148, pp. 731- 738 ,(1996)
M. R. Stratton, C. Fisher, C. S. Cooper, B. A. Gusterson, Detection of Point Mutations in N-ras and K-ras Genes of Human Embryonal Rhabdomyosarcomas Using Oligonucleotide Probes and the Polymerase Chain Reaction Cancer Research. ,vol. 49, pp. 6324- 6327 ,(1989)
Guoren Deng, Youyong Lu, Shiming Chen, Jing Miao, Guirong Lu, Hua Li, Hong Cai, Xinlai Xu, Zheng E, Peinan Liu, None, Activated c-Ha-ras oncogene with a guanine to thymine transversion at the twelfth codon in a human stomach cancer cell line. Cancer Research. ,vol. 47, pp. 3195- 3198 ,(1987)
Koichi Fujita, Noriaki Ohuchi, Tsuneyoshi Yao, Makoto Okumura, Yukio Fukushima, Yuzuru Kanakura, Yukihiko Kitamura, Jun Fujita, Frequent overexpression, but not activation by point mutation, of ras genes in primary human gastric cancers. Gastroenterology. ,vol. 93, pp. 1339- 1345 ,(1987) , 10.1016/0016-5085(87)90264-2
Takashi Tokino, Takashi Tokino, Bert Vogelstein, Kenneth W. Kinzler, David Sidransky, David E. Hill, Jonathan D. Oliner, Sharon Smith, Marilee Burrell, Fredrick S. Leach, Paul Meltzer, p53 Mutation and MDM2 Amplification in Human Soft Tissue Sarcomas Cancer Research. ,vol. 53, pp. 2231- 2234 ,(1993)
Johannes L. Bos, The ras gene family and human carcinogenesis Mutation Research/Reviews in Genetic Toxicology. ,vol. 195, pp. 255- 271 ,(1988) , 10.1016/0165-1110(88)90004-8
J.L. Bos, M.Verlaan-de Vries, C.J. Marshall, G.H. Veeneman, J.H. van Boom, A.J. van der Eb, A human gastric carcinoma contains a single mutated and an amplified normal allele of the Ki-ras oncogene Nucleic Acids Research. ,vol. 14, pp. 1209- 1217 ,(1986) , 10.1093/NAR/14.3.1209